BTIG Research downgraded Sharecare from Buy to Neutral
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/1/2024 | Buy → Neutral | BTIG Research | |
| 7/20/2022 | $2.50 | Equal-Weight | Morgan Stanley |
| 2/11/2022 | $4.50 | Neutral | Goldman |
| 2/11/2022 | Neutral | Goldman Sachs | |
| 8/4/2021 | $11.00 | Buy | Canaccord Genuity |
| 7/28/2021 | $15.00 | Buy | BTIG Research |